Biography
Mikhail G Kolonin is an Associate Professor and Director of the Center for Metabolic and Degenerative Diseases at the University of Texas in Houston. As a Ph.D. from Wayne State University, he pioneered the concept of expressing peptides disrupting protein interactions in animals. As a Postdoctoral fellow at MD Anderson Cancer Center, he screened combinatorial libraries to identify druggable cell surface markers. Based on this approach, he has invented experimental therapeutics for obesity and cancer. He is an Author of over 60 publications and has editorial positions with Molecular Carcinogenesis and Cancer Research. He is endowed with a Distinguished University Chair in Metabolic Disease Research.
Research Interest
He has invented experimental therapeutics for obesity and cancer. He is an Author of over 60 publications and has editorial positions with Molecular Carcinogenesis and Cancer Research. He is endowed with a Distinguished University Chair in Metabolic Disease Research.
Biography
Dr. Arturo SolÃs Herrera, MD, PhD., has been Graduated from Institute Polytechnic Nacional, from CDMX, in 1978 as Medicine Doctor, with the specialties including Ophthalmology, in the National University of Mexico, and Neuro-Ophthalmology, at INNN, México. Later on he obtained his Master Science Degree from University of Aguascalientes, México, and thereafter a PhD in Pharmacology, Universidad de Guadalajara, México. Dr. SolÃs Herrera is director and founder of Human Photosynthesis® Research Center, in Ags., México, in 2007; where he has continued his research until today.
Research Interest
The discovery of a biochemical process, that from a molecule that exists on the skin, hair and coating the human retina but can be produced artificially, (melanin or polihidroxiindol), is capable of breaking the molecule water, separating the hydrogen and oxygen and extracting energy from this process. The raw material of this invention is abundant in nature, as its core components are water and a molecule that exists in the skin, hair and the lining of the human retina, but that can be produced artificially: melanin or polihidroxiindol.
Biography
Douglas N Ishii received his BA in Biochemistry from the University of California, Berkeley, and Ph.D. in Pharmacology from Stanford University Medical School and conducted Postdoctoral work in Neurobiology at Stanford. He became an Assistant and then Associate Professor of Pharmacology at Columbia University, New York City. He is a Professor of Biomedical Sciences at Colorado State University. He served on various scientific study sections for the National Science Foundation, the National Institutes of Health, and The Juvenile Diabetes International Foundation. Press coverage on his laboratory’s research on the pathogenesis of diabetic neurological complications, and the cause of brain atrophy in Alzheimer’s disease, include articles in Der Spiegel, Hong Kong Standard, NY Times, LA Times, Denver Post, Chicago Tribune, ABC News, Forbes News, USA. Today, National Public Radio, and elsewhere. Nineteen patients were awarded based on this research.
Research Interest
Laboratory research on the pathogenesis of diabetic neurological complications, and the cause of brain atrophy in Alzheimer’s disease.
